Top Markets
#1 Fabric Protocol Fabric Protocol +32.06%
#2 Binance-Peg Bitcoin Cash Binance-Peg Bitcoin Cash +31.94%
#3 Tutorial Tutorial +31.67%
#4 Bitcoin Cash Bitcoin Cash +31.12%
#5 GALA GALA +30.99%
#6 Audiera Audiera +30.55%
#7 Zora Zora +26.33%
#8 GoPlus Security GoPlus Security +26.04%
#9 Arowana Arowana +25.32%
#10 Talus Network Talus Network +24.98%
Coin of the day
Fabric Protocol Fabric Protocol
설정
언어
한국어
통화
USD
테마
Lytix Biopharma AS Lytix Biopharma AS

Lytix Biopharma AS

LYTIX
주식 순위 #24454
Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology... Based in Oslo, Norway, Lytix Biopharma ASA is a clinical-stage biotechnology firm dedicated to advancing innovative immunotherapies for cancer treatment. Its primary drug candidate, LTX-315, is an oncolytic molecule currently undergoing Phase II clinical trials. This therapy is formulated for intratumoral injection, aiming to provide localized treatment for solid tumors. Additionally, Lytix Biopharma is developing LTX-401, another oncolytic molecule in its preclinical phase, specifically designed to target deep-seated cancerous lesions, including those found in liver cancer. The company was established in 2003.
주가
$0.78611575
시가총액
$60.45M
변동 (1일)
0.00%
변동 (1년)
-12.06%
국가
NO
거래 Lytix Biopharma AS (LYTIX)

카테고리

Healthcare
Lytix Biopharma AS (LYTIX)의 주식 분할 이력
Lytix Biopharma AS 주식 (심볼: LYTIX)은 총 0회의 주식 분할을 거쳤습니다.
가장 최근의 분할은 Aug 21, 2026에 발생했습니다.
Aug 21, 2026 이전에 매수한 LYTIX 주식 1주는 현재 0주의 LYTIX 주식에 해당합니다.
주식 분할 목록
연도 주식 분할 배수 누적 배수
제공된 날짜에 대한 데이터가 충분하지 않습니다.
유사 기업 또는 경쟁사의 주식 분할
회사 주식 분할 횟수 누적 배수 국가
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 1 x2
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 0 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 1 x3
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 0 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 0 -
CH